3种常用抗癌药物对人肝癌细胞HepG2抑制作用的研究
Inhibition research of three commonly-used anti-tumor drugs against HepG2 cell line
-
摘要: 目的:研究3种常用抗癌药物对于HepG2细胞的抑制情况。方法:细胞铺96孔板,3种抗癌药物以不同浓度给药,每浓度设3复孔,不加药组做空白对照,MTT法测定,以抑制率对药物浓度作图。结果:在1~420μg/mL浓度范围内,5-氟尿嘧啶抑制效果最差;20~300μg/mL丝裂霉素C抑制效果好于长春新碱;1~20μg/mL和300~420μg/mL浓度范围内,长春新碱抑制效果好于丝裂霉素C。结论:该方法评价对比了3种常用的抗癌药物对于人肝癌细胞的抑制效果,为药物筛选中阳性药物的选择提供一定借鉴。Abstract: Objective :To establish an inhibition research method of three commonly-used anti-tumor drugs against HepG2 cell line. Methods : The determination was performed on a 96-well plate.The drugs were administrated in a series of concentrations,and each concentration was triplicate.Cells without drugs were set as a negative control.Followed by determination of MTT method,the inhibition ratio was plotted to concentration. Results :The inhibition ability of 3 drugs were different when the concentration were in different range.On the whole,the inhibition ability of 5-Fu was the weakest one. Conclusion :The method evaluates and compares the inhibition ability of 3 commonly-used anti-tumor drugs against HepG2 cell line,and could be a reference in positive control of drug screening experiment.
-
Key words:
- MTT /
- HepG2 /
- IC50 /
- 5-Fu /
- Vincristine /
- Mitomycin C
计量
- 文章访问数: 2239
- HTML全文浏览量: 230
- PDF下载量: 1413
- 被引次数: 0